FIELD: medicine.
SUBSTANCE: invention describes a method for assessing the copper nanoparticles administration safety consisting in measuring caspase-3 antigen expression in microglial cells of the cortical sensorimotor area after copper nanoparticles introduction in comparison with control animals by caspase-3 expressing microglial cell count per a standard area unit of the identical sensorimotor areas.
EFFECT: method enables determining a tolerance of the preparation to be administered, specifying target organs, choosing the most adequate administration route.
2 cl, 5 ex, 6 tbl, 12 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF COMBINED LIVER CANCER PC-1 THERAPY IN EXPERIMENT | 2020 |
|
RU2734143C1 |
| METHOD FOR SIMULATING OSTEOARTHROSIS | 2015 |
|
RU2587039C1 |
| METHOD FOR SIMULATING ENDOTHELIAL DYSFUNCTION AND PATHOLOGY OF INTERNAL ORGANS IN EXPERIMENT | 2019 |
|
RU2712102C1 |
| METHOD FOR SIMULATING CHRONIC ALCOHOL INTOXICATION IN EXPERIMENTAL RATS | 2020 |
|
RU2740569C1 |
| METHOD OF ASSESSING THE TOXIC EFFECT OF A BIMETALLIC FERRUM-GADOLINIUM NANOCOMPOSITE ENCAPSULATED IN A NATURAL POLYMER MATRIX OF ARABINOGALACTAN ON LABORATORY ANIMALS | 2019 |
|
RU2733504C1 |
| METHOD OF PREVENTING TOXIC EFFECT OF CADMIUM IN EXPERIMENTAL ANIMALS | 2009 |
|
RU2410763C1 |
| LOW-TOXICITY PHARMACEUTICAL COMPOSITION WITH ANTICANCER ACTIVITY AGAINST CHOLANGIOCARCINOMA | 2023 |
|
RU2825942C1 |
| METHOD OF TREATING SYSTEMIC YERSINIA-CAUSED BACTERIAL INFECTIONS EXPERIMENTALLY | 2014 |
|
RU2563174C1 |
| METHOD OF TREATING INFECTIOUS PERITONITIS EXPERIMENTALLY | 2014 |
|
RU2553342C1 |
| METHOD OF RESTORATION OF AFFECTED LIVER PARENCHYMA IN RATS | 2009 |
|
RU2398290C1 |
